You are currently viewing a new version of our website. To view the old version click .
Proceedings
  • Abstract
  • Open Access

8 August 2025

Genomic Characterization and Classification of Streptococcus oralis Using Next-Generation Sequencing †

,
,
,
,
,
,
,
,
and
1
Department of Biological Sciences, Lebanese American University, Byblos 36, Lebanon
2
General Laboratory, Middle East Institute of Health—University Hospital, Beirut 20220, Lebanon
3
Medical School, Holy Spirit University of Kaslik, Jounieh 446, Lebanon
*
Author to whom correspondence should be addressed.
This article belongs to the Proceedings The 22nd Lancefield International Symposium on Streptococci and Streptococcal Diseases (LISSSD 2025)
Streptococcus oralis is an alpha-hemolytic, Gram-positive bacterium from the viridans group streptococci (VGS). While commonly part of the normal oral flora, its role in extraoral infections is increasingly recognized. Reported infections include endocarditis, meningitis, and urinary tract infections (UTIs). In this study, we describe a rare case of a S. oralis-associated UTI in an 83-year-old male with a history of recurrent infections. Genomic characterization using short- and long-read sequencing revealed multiple virulence factors and antimicrobial resistance determinants. The isolate was resistant to cefepime and ceftriaxone, an uncommon phenotype in S. oralis. Key virulence genes detected included nanA, ribX, speA, scpB, and lytB. Phylogenetic analysis showed high sequence similarity to S. oralis subsp. oralis and S. oralis subsp. dentisani. Importantly, we also identified homologs of the Type VII Secretion System (T7SS) components EssC and EsxA, supported by PFAM domain analysis and phylogenetic clustering within canonical T7SS lineages. Ongoing work is focused on characterizing the genetic context of these T7SS-associated genes to better understand their regulation and potential role in virulence. These findings will expand current knowledge of S. oralis pathogenicity and highlight the value of genomic surveillance in detecting emerging virulence pathways in VGS members.

Author Contributions

Conceptualization, S.T., R.S. and E.A.; methodology, G.C., N.A.B. and S.T.; software, R.A., C.A., C.B., R.M. and P.S.; validation, S.T. and C.A.K.; formal analysis, S.T., C.A.K., G.C., R.A., C.A., C.B., R.M. and P.S.; investigation, S.T., C.A.K., G.C., N.A.B., R.A., C.A., C.B., R.M., P.S., E.A. and R.S.; resources, S.T., E.A. and R.S.; writing—original draft preparation, S.T.; writing—review and editing, S.T., C.A.K., E.A. and R.S.; supervision, S.T.; C.A.K., E.A. and R.S.; project administration, S.T.; funding acquisition, S.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical approval was not required for this study as it involved the analysis of bacterial isolates obtained during routine clinical diagnostics. No identifiable patient information was collected or used, and all data were anonymized prior to analysis.

Data Availability Statement

The genome sequence generated in this study has been deposited in NCBI under BioSample accession number SAMN39979533.

Conflicts of Interest

No conflict of interest to declare.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.